Maynard Um
-
-
-
-
-
-
-
BMO Capital Reiterates Outperform Rating on Vertex (VRTX)
-
-
-
-
-
-
-
Vertex Pharma (VRTX) Added to BofA US 1 List
-
-
-
-
-
-
-
Vertex (VRTX) PT Raised to $595 at Cantor Fitzgerald on Uniquely Attractive Optionality
-
-
-
-
-
-
-
Jones Trading Downgrades Crinetics (CRNX) to Hold
-
-
-
-
-
-
-
FDA approves Casgevy gene therapy for sickle cell in children 2+
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on Vertex (VRTX) Post Q1 Print
-
-
-
-
-
-
-
These are the best biotech stocks to own in 2026: BofA
-
470,284 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


